Ardevora Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Ardevora Asset Management's GILD Position: Q4 2023 in Review
Ardevora Asset Management reduced its Gilead Sciences (GILD) stake by 47% in Q4 2023, selling an estimated $8.58M and leaving 125,943 shares worth $10.2M. The position accounts for 0.91% of the portfolio, ranked #64.
Ardevora Asset Management first reported a position in GILD in Q4 2014 and has held it in 13 quarters since. The position peaked at $66.6M in Q4 2022. 1,775 funds tracked by Wall St. Rank hold GILD as of Q4 2023.
- Ardevora Asset Management held 125,943 shares of Gilead Sciences worth $10.2M as of Q4 2023.
- Ardevora Asset Management sold 110,281 Gilead Sciences shares in Q4 2023, an estimated $8.58M.
- Gilead Sciences made up 0.91% of Ardevora Asset Management's portfolio in Q4 2023, its #64 holding.
- Ardevora Asset Management first reported a position in Gilead Sciences in Q4 2014 and has held it in 13 quarters since.
- Ardevora Asset Management's Gilead Sciences position peaked at $66.6M in Q4 2022.
- 1,775 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.
Based on Ardevora Asset Management's 13F filing for Q4 2023, filed 1 Feb 2024.